This article was written by Follow Victor Dergunov is an independent investor and author with 20 years experience. He preaches diversification and shares investment...
By Jeffrey Schulze, CFA, Investment Strategist, ClearBridge Investments In this episode, we speak with Jeff Schulze, head of economic and market research at ClearBridge...
Investment Summary Following a series of investment updates since my April publication on Avanos Medical, Inc. (NYSE:AVNS), there is still the potential to unlock...
Introduction Invitae (NYSE:NVTA) is a leading provider of genetic testing services, digital health solutions, and health data services. Their genetic tests cover various clinical...